Intravenous-to-enteral drug substitution in the ICU: a single-centre analysis of the potential to reduce the environmental footprint of critical care - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating the Transition from Intravenous to Enteral Medications in the ICU: A Single-Center Study on Reducing the Environmental Impact of Critical Care

  • By

  • Clémence Marois

  • Maxime Gasperment

  • Adam Celier

  • Ambre Preteux

  • Grégoire Gaucher

  • Léontine Scherer

  • Nicolas Weiss

  • Kevin Bihan

  • Marie Lecronier

  • Amélie Liou

  • September 22, 2026

Share

Original Source(s)

Intravenous-to-enteral drug substitution in the ICU: a single-centre analysis of the potential to reduce the environmental footprint of critical care

  • by Clémence Marois, Maxime Gasperment, Adam Celier, Ambre Preteux, Grégoire Gaucher, Léontine Scherer, Nicolas Weiss, Kevin Bihan, Marie Lecronier, Amélie Liou

  • September 22, 2026

Related Content

2026 Zenith Award Winners Announced

DTR Stenotrophomonas maltophilia pneumonia: the unseen denominator and the limits of inference

Trends in the Use and Costs of Medications for Respiratory Management Included in the 2022 Benefit Plan of the Colombia Health System